Proteogenomic Characterization Unveils Biomarkers Associated With Chemoresistance in Muscle Invasive Bladder Cancer
Demographics (3)
- Age - Subject age at diagnosis (phv00560327.v1.p1)
- COLLECTION_AGE - Subject age at diagnosis (phv00560334.v1.p1)
- SEX - Biological sex (phv00560320.v1.p1)
Disease Events (7)
- AFFECTION_STATUS - Case control status of the subject for Muscle Invasive Bladder Cancer (MIBC); all subjects are MIBC patients. (phv00560325.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample/Clinical_Histology_type (phv00560333.v1.p1)
- IS_TUMOR - Tumor status (phv00560332.v1.p1)
- MEDICAL_TREATMENT - Status of radical cystectomy or radiation therapy (phv00560328.v1.p1)
- TUMOR_GRADE - Tumor grade of sample/Clinical_Grade (phv00560336.v1.p1)
- TUMOR_STAGE - Tumor stage of sample/Clinical_Stage_T (phv00560335.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00560337.v1.p1)
Race and Ethnicity (1)
- Race - Self-reported race (phv00560326.v1.p1)
Other (9)
- ANALYTE_TYPE - Analyte Type (phv00560331.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00560330.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00560319.v1.p1)
- SAMPLE_ID - Sample ID (phv00560329.v1.p1)
- SAMPLE_ID - Sample ID (phv00560323.v1.p1)
- SUBJECT_ID - Subject ID (phv00560324.v1.p1)
- SUBJECT_ID - Subject ID (phv00560318.v1.p1)
- SUBJECT_ID - Subject ID (phv00560322.v1.p1)
- SUBJECT_SOURCE - Sample collection institute (phv00560321.v1.p1)